Please wait...

Malaria

December 23, 2016 by cemtrod4

Abstract Although global morbidity and mortality have decreased substantially, malaria, a
parasite infection of red blood cells, still kills roughly 2000 people per day, most of whom are
children in Africa. Two factors largely account for these decreases; increased deployment of
insecticide-treated bednets and increased availability of highly effective artemisinin
combination treatments. In large trials, parenteral artesunate (an artemisinin derivative)
reduced severe malaria mortality by 22· 5% in Africa and 34· 7% in Asia compared with


4 comments

  • admin

    October 16, 2015 at 7:34 am

    Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

    Reply

    • admin

      October 16, 2015 at 10:26 am

      Diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

      Reply

  • admin

    October 16, 2015 at 7:34 am

    Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

    Reply

    • admin

      October 16, 2015 at 10:26 am

      Diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *


Malaria remains a major public health problem in Africa and particularly in Nigeria. Focused research for development of new tools and providing evidence for appropriate interventions remain critical to its control. Malaria research in Nigeria had over the years been conducted mostly in Southern part of the country with the main capacities limited to just 2-3 Institutions.

Copyright by Centre For Malaria and Other Tropical Diseases 2016. All rights reserved.